Christine Zurawski, MD

NPI 1447365762ActiveIndividual· Internal Medicine, Infectious Disease· Atlanta, GA

Internal Medicine, Infectious Disease (MD) in Atlanta, Georgia, trained at Emory University School of Medicine (class of 1991). Their prescriptions cost Medicare Part D more than their services did: $1,351,258 for 517 claims, against $218,503 paid for services in 2024. Gilead Sciences, Inc. was the largest of 15 companies reporting payments in 2025, $1,197 in all, mostly food and beverage.

Overview

NPI	1447365762
Status	Active
Entity type	Individual
Credential	MD
Sole proprietor	No
NPI issued	Aug 19, 2006
Last updated in NPPES	Feb 20, 2013

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Infectious Disease Primary	207RI0200X	36328	GA

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Infectious Disease (GA)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	137
Services billed	3,862 across 39 procedure codes
Paid by Medicare	$218,503

Part D prescriptions in 2024

Prescriptions (claims)	517 · 722 30-day fills
Patients	81
Total drug cost	$1,351,258
Generic share	41% of claims

Medicare sources and data years

Education and affiliations

Medical school	Emory University School of Medicine
Graduation year	1991
Medicare specialty	Infectious Disease
Secondary specialties	Internal Medicine
Telehealth	Offers telehealth